Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119267) titled 'The Impact of Remimazolam Bensulfonate on Hemodynamics in Surgical Patients' on Feb. 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fuwai Central China Cardiovascular Hospital
Condition:
Heart disease
Intervention:
Rimazolen group:Peripheral intravenous infusion of 0.2-0.3mg/kg of remifentanil sulfonate, completed within 1 minute
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-26
Target Sample Size: Rimazolen group:100;Control group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3...